Holen Sie sich die Stockscreener-App
16.69
6.29%
-1.12
Vorhandelsmarkt:
16.68
-0.01
-0.06%
Schlusskurs vom Vortag:
$17.81
Offen:
$17.81
24-Stunden-Volumen:
1.69M
Relative Volume:
1.78
Marktkapitalisierung:
$826.66M
Einnahmen:
$341.22M
Nettoeinkommen (Verlust:
$21.78M
KGV:
37.93
EPS:
0.44
Netto-Cashflow:
$26.30M
1W Leistung:
-10.65%
1M Leistung:
-12.30%
6M Leistung:
-39.79%
1J Leistung:
-59.81%
1-Tages-Spanne:
$16.16
$17.85
1-Wochen-Bereich:
$16.16
$19.33
52-Wochen-Spanne:
$13.50
$49.86
Staar Surgical Co Stock (STAA) Company Profile
Firmenname
Staar Surgical Co
Sektor
Telefon
(626) 303-7902
Adresse
1911 WALKER AVE, MONROVIA, CA
Vergleichen Sie STAA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
STAA
Staar Surgical Co
|
16.69 | 937.03M | 341.22M | 21.78M | 26.30M | 0.44 |
|
ISRG
Intuitive Surgical Inc
|
553.29 | 197.20B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
169.40 | 50.02B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
85.17 | 42.88B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
244.03 | 36.10B | 5.02B | 1.31B | 1.56B | 8.91 |
|
BAX
Baxter International Inc
|
29.55 | 15.84B | 11.89B | -560.00M | 191.00M | -1.10 |
Staar Surgical Co Stock (STAA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-21 | Eingeleitet | Wells Fargo | Equal Weight |
| 2025-02-12 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-02-12 | Herabstufung | Jefferies | Buy → Hold |
| 2025-02-12 | Herabstufung | Mizuho | Outperform → Neutral |
| 2025-02-12 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2024-07-15 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2024-06-11 | Hochstufung | BTIG Research | Neutral → Buy |
| 2024-03-11 | Hochstufung | Stifel | Hold → Buy |
| 2023-12-05 | Herabstufung | Needham | Buy → Hold |
| 2023-12-04 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2023-09-15 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2023-08-03 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2023-06-07 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2023-04-17 | Eingeleitet | Piper Sandler | Neutral |
| 2023-02-06 | Herabstufung | BTIG Research | Buy → Neutral |
| 2022-12-28 | Bestätigt | BTIG Research | Buy |
| 2022-12-08 | Eingeleitet | Stifel | Hold |
| 2022-11-07 | Hochstufung | Sidoti | Neutral → Buy |
| 2022-10-14 | Fortgesetzt | Stephens | Overweight |
| 2022-10-13 | Eingeleitet | Mizuho | Buy |
| 2022-04-08 | Eingeleitet | Needham | Buy |
| 2022-03-28 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2022-03-18 | Hochstufung | BTIG Research | Neutral → Buy |
| 2021-07-09 | Eingeleitet | Oppenheimer | Perform |
| 2021-01-19 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2020-10-26 | Herabstufung | Sidoti | Buy → Neutral |
| 2020-08-31 | Hochstufung | Sidoti | Neutral → Buy |
| 2020-08-06 | Bestätigt | The Benchmark Company | Buy |
| 2020-07-06 | Herabstufung | Sidoti | Buy → Neutral |
| 2020-06-24 | Herabstufung | BTIG Research | Buy → Neutral |
| 2020-06-15 | Eingeleitet | Jefferies | Buy |
| 2019-12-04 | Eingeleitet | BTIG Research | Buy |
| 2018-09-24 | Bestätigt | The Benchmark Company | Buy |
| 2018-08-06 | Fortgesetzt | The Benchmark Company | Buy |
| 2017-11-20 | Bestätigt | The Benchmark Company | Buy |
| 2017-08-14 | Bestätigt | The Benchmark Company | Buy |
| 2017-03-03 | Bestätigt | The Benchmark Company | Buy |
| 2016-05-18 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2013-09-10 | Fortgesetzt | The Benchmark Company | Buy |
| 2013-02-28 | Bestätigt | The Benchmark Company | Buy |
| 2012-11-01 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2012-03-02 | Eingeleitet | Northland Securities | Outperform |
| 2011-10-25 | Bestätigt | The Benchmark Company | Buy |
| 2010-10-12 | Eingeleitet | Morgan Joseph | Buy |
| 2010-05-11 | Eingeleitet | Benchmark | Buy |
Alle ansehen
Staar Surgical Co Aktie (STAA) Neueste Nachrichten
Staar Surgical Co (STAA) Trading Down 3.22% on May 30 - GuruFocus
Midday Stock Roundup: Tilly’s Up 14% Ahead of Q1 Results - Orange County Business Journal
Staar Surgical Co (STAA) Stock Price Down 4.12% on May 28 - GuruFocus
Why LASIK Isn't for Everyone: Houston Lasik & Eye Introduces EVO ICL as a Personalized Solution - USA Today
Canaccord Genuity Maintains Hold Rating for STAA with $20 Price Target | STAA Stock News - GuruFocus
STAAR Surgical (NASDAQ:STAA) Receives Hold Rating from Canaccord Genuity Group - Defense World
STAAR Surgical at Stifel Forum: Strategic Moves and Market Challenges - Investing.com Australia
STAAR Surgical at Stifel Forum: Strategic Moves and Market Challenges By Investing.com - Investing.com India
Staar Surgical Q1 Sales Drop 45% on Weak China Demand - Orange County Business Journal
Deutsche Bank AG Has $1.10 Million Stake in STAAR Surgical (NASDAQ:STAA) - Defense World
Ameriprise Financial Inc. Raises Position in STAAR Surgical (NASDAQ:STAA) - Defense World
STAAR Surgical Announces Participation in Upcoming Investor Conferences - Yahoo Finance
Fortune Brands, Whirlpool, Align Technology, Tandem Diabetes, and STAAR Surgical Shares Plummet, What You Need To Know - Yahoo Finance
Staar Surgical (STAA) Receives 'Hold' Rating Reiteration from Ne - GuruFocus
STAAR Surgical stock target raised at Jefferies to $21 By Investing.com - Investing.com South Africa
STAAR Surgical stock target raised at Jefferies to $21 - Investing.com Australia
STAAR Surgical (NASDAQ:STAA) Shares Bought by BNP Paribas Financial Markets - Defense World
STAAR Surgical Company look to conduct $30M share buyback program - MSN
Staar Surgical Co (STAA) Getting Ready To Launch, Waiting For The Long Term Buyers - Stocksregister
Northern Trust Corp Reduces Stock Holdings in STAAR Surgical (NASDAQ:STAA) - Defense World
STAAR Surgical authorizes $30 million stock buyback By Investing.com - Investing.com South Africa
STAAR Surgical authorizes $30 million stock buyback - Investing.com Australia
Staar Surgical Announces $30 Million Share Repurchase Authorization - marketscreener.com
Staar Surgical (STAA) Board Approves $30 Million Share Buyback | - GuruFocus
STAAR Surgical Announces Major Stock Buyback: $30M Program Signals Management Confidence - Stock Titan
How Implantable Collamer Lenses Market: Improve Vision Clarity By 2031 - openPR.com
Global Intraocular Lens Market to Witness Upsurge in Growth at a CAGR of ~5% by 2032 | DelveInsight - GlobeNewswire
STAAR Surgical (NASDAQ:STAA) Position Reduced by Tower Research Capital LLC TRC - Defense World
The STAAR Surgical Company (NASDAQ:STAA) First-Quarter Results Are Out And Analysts Have Published New Forecasts - Yahoo
Staar Surgical (STAA) Price Target Raised by Canaccord Genuity | - GuruFocus
Quarterly Snapshot: Quick and Current Ratios for Staar Surgical Co (STAA) - DWinneX
STAAR Surgical Company (NASDAQ:STAA) Q1 2025 Earnings Call Transcript - Insider Monkey
STAAR Surgical’s Earnings Call: Growth Amid Challenges - TipRanks
Staar Surgical Withdraws FY 2025 Guidance Amid Tariffs & Economic Uncertainty - Medical Device and Diagnostic industry
Stifel maintains $20 target, Buy rating on STAAR Surgical stock - Investing.com
Stifel maintains $20 target, Buy rating on STAAR Surgical stock By Investing.com - Investing.com UK
STAAR Surgical projects significant China revenue rebound in Q3 2025 amid tariff mitigation and new product launch - MSN
Canaccord raises STAAR Surgical stock target to $20, maintains Hold By Investing.com - Investing.com Australia
Canaccord raises STAAR Surgical stock target to $20, maintains Hold - Investing.com
Canaccord Increases Price Target for Staar Surgical (STAA) Despi - GuruFocus
Canaccord Increases Price Target for Staar Surgical (STAA) Despite Challenging Q1 | STAA Stock News - GuruFocus
STAAR Surgical Q1 2025 Earnings Report - MarketBeat
Staar Surgical Co (STAA) Q1 2025 Earnings Call Highlights: Navigating Challenges and Optimizing ... - Yahoo Finance
STAAR Surgical Surpasses Wall Street Expectations Amid Revenue DropNews and Statistics - IndexBox
Staar Surgical Co (STAA) Q1 2025 Earnings Call Highlights: Navigating Challenges and Optimizing Growth Strategies - GuruFocus
Staar Surgical: Q1 Earnings Snapshot - New Haven Register
STAAR Surgical earnings missed by $0.52, revenue topped estimates - Investing.com
Earnings call transcript: STAAR Surgical misses Q1 2025 EPS forecast, stock dips - Investing.com Australia
Finanzdaten der Staar Surgical Co-Aktie (STAA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.04%
1.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):